 |
 Video: What is a Stock Split?
|
|
|
| Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick. According to our TEVA split history records, Teva Pharmaceutical Industries has had 5 splits. | |
|
Teva Pharmaceutical Industries (TEVA) has 5 splits in our TEVA split history database. The first split for TEVA took place on April 14, 1993. This was a 2 for 1
split, meaning for each share of TEVA owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split. TEVA's second split took place on February 23, 2000. This was a 2 for 1
split, meaning for each share of TEVA owned pre-split, the shareholder now owned 2 shares. For example, a 2000 share position pre-split, became a 4000 share position following the split. TEVA's third split took place on February 22, 2000. TEVA's 4th split took place on December 06, 2002. This was a 2 for 1 split, meaning for each share of TEVA owned pre-split, the shareholder now owned 2 shares. For example, a 4000 share position pre-split, became a 8000 share position following the split. TEVA's 5th split took place on July 01, 2004. This was a 2 for 1 split, meaning for each share of TEVA owned pre-split, the shareholder now owned 2 shares. For example, a 8000 share position pre-split, became a 16000 share position following the split.
When a company such as Teva Pharmaceutical Industries splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the TEVA split history from start to finish, an original position size of 1000 shares would have turned into 16000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Teva Pharmaceutical Industries shares, starting with a $10,000 purchase of TEVA, presented on a split-history-adjusted basis factoring in the complete TEVA split history.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
09/12/2014 |
|
| End date: |
09/10/2024 |
|
| Start price/share: |
$52.08 |
|
| End price/share: |
$17.52 |
|
| Starting shares: |
192.01 |
|
| Ending shares: |
209.74 |
|
| Dividends reinvested/share: |
$3.89 |
|
| Total return: |
-63.25% |
|
| Average Annual Total Return: |
-9.52% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$3,676.27 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/12/2014 |
|
| End date: |
09/10/2024 |
|
| Start price/share: |
$52.08 |
|
| End price/share: |
$17.52 |
|
| Dividends collected/share: |
$3.89 |
|
| Total return: |
-58.89% |
|
| Average Annual Total Return: |
-8.50% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,112.49 |
|
| Years: |
10.00 |
|
|
|
| Date |
Ratio |
| 04/14/1993 | 2 for 1
| | 02/23/2000 | 2 for 1
| | 02/22/2000 | 1 for 1 | | 12/06/2002 | 2 for 1 | | 07/01/2004 | 2 for 1 |
|
|
Free TEVA Email Alerts:
